AP-768
780763-95-3
|
ap-1-(9-fluorenyl)-2-(1-methylethenyl)naphthalene
134864-90-7
|
AP-III-a4
1177827-73-4
|
AP-1/NF-κB activation inhibitor 1
188936-12-1
|
AP-18
55224-94-7
|
AP C5
2234272-10-5
|
AP-III-a4 hydrochloride
2070014-95-6
|
AP 20187
195514-80-8
|
AP 1903
195514-63-7
|
2,2-Difluoro-2-(4-(trifluoromethyl)thiazol-2-yl)acetic acid
2639440-55-2
|
6-(Dimethylphosphoryl)cyclohex-1-ene-1-carboxylic acid
2639405-80-2
|
tert-butylN-(5-bromo-1-methyl-1H-1,3-benzodiazol-2-yl)carbamate
2639426-62-1
|
2-[5-(2-chlorophenyl)-1H-1,3-benzodiazol-2-yl]ethan-1-amine
2639403-73-7
|
2-(2-{[(9H-fluoren-9-yl)methoxy]carbonyl}-2-azabicyclo[2.2.1]heptan-4-yl)aceticacid
2639440-60-9
|
2,2-Difluoro-2-(5-methyl-2-(trifluoromethyl)thiazol-4-yl)acetic acid
2639413-90-2
|
7,7-Dimethyl-4-(pyridin-3-yl)-3,8-dioxatricyclo[7.4.0.0,2,6]trideca-1(9),10,12-triene-11-carboxylic acid
2639442-00-3
|
Methyl 2-[6-(trifluoromethyl)morpholin-3-yl]acetate
2639412-74-9
|
3-[4-Bromo-2-(trifluoromethyl)phenyl]oxetan-3-amine
2639412-94-3
|
rac-2-[(2R,5S)-5-methyl-1,4-dioxan-2-yl]ethan-1-amine
2639377-75-4
|
